CP-751,871's Safety, Tolerability, and Maximum Tolerated Dose Defined in First-in-Human Multiple Myeloma Study
CP-751,871 Treatment For Patients With Multiple Myeloma
Abstract
CP-751,871's safety, tolerability, and maximum tolerated dose were successfully defined in its first-in-human dose escalation study for multiple myeloma patients.